These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

123 related articles for article (PubMed ID: 26093645)

  • 21. Tuning fork (128 Hz) versus neurothesiometer: a comparison of methods of assessing vibration sensation in patients with diabetes mellitus.
    O'Neill J; McCann SM; Lagan KM
    Int J Clin Pract; 2006 Feb; 60(2):174-8. PubMed ID: 16451290
    [TBL] [Abstract][Full Text] [Related]  

  • 22. Decision making by NICE: examining the influences of evidence, process and context.
    Cerri KH; Knapp M; Fernández JL
    Health Econ Policy Law; 2014 Apr; 9(2):119-41. PubMed ID: 23688554
    [TBL] [Abstract][Full Text] [Related]  

  • 23. Evaluation of clinical tools and their diagnostic use in distal symmetric polyneuropathy.
    Pourhamidi K; Dahlin LB; Englund E; Rolandsson O
    Prim Care Diabetes; 2014 Apr; 8(1):77-84. PubMed ID: 23664849
    [TBL] [Abstract][Full Text] [Related]  

  • 24. Utility values in National Institute for Health and Clinical Excellence (NICE) Technology Appraisals.
    Tosh JC; Longworth LJ; George E
    Value Health; 2011 Jan; 14(1):102-9. PubMed ID: 21211492
    [TBL] [Abstract][Full Text] [Related]  

  • 25. WatchBP Home A for opportunistically detecting atrial fibrillation during diagnosis and monitoring of hypertension: a NICE Medical Technology Guidance.
    Willits I; Keltie K; Craig J; Sims A
    Appl Health Econ Health Policy; 2014 Jun; 12(3):255-65. PubMed ID: 24664995
    [TBL] [Abstract][Full Text] [Related]  

  • 26. Evidence Review Group approaches to the critical appraisal of manufacturer submissions for the NICE STA process: a mapping study and thematic analysis.
    Kaltenthaler E; Boland A; Carroll C; Dickson R; Fitzgerald P; Papaioannou D
    Health Technol Assess; 2011 May; 15(22):1-82, iii-iv. PubMed ID: 21561569
    [TBL] [Abstract][Full Text] [Related]  

  • 27. Review of the role of NICE in promoting the adoption of innovative cardiac technologies.
    Groves PH; Pomfrett C; Marlow M
    Heart; 2018 Nov; 104(22):1817-1822. PubMed ID: 29773657
    [TBL] [Abstract][Full Text] [Related]  

  • 28. Effectiveness of Semmes-Weinstein monofilament examination for diabetic peripheral neuropathy screening.
    Kamei N; Yamane K; Nakanishi S; Yamashita Y; Tamura T; Ohshita K; Watanabe H; Fujikawa R; Okubo M; Kohno N
    J Diabetes Complications; 2005; 19(1):47-53. PubMed ID: 15642490
    [TBL] [Abstract][Full Text] [Related]  

  • 29. A novel robotic monofilament test for diabetic neuropathy.
    Wilasrusmee C; Suthakorn J; Guerineau C; Itsarachaiyot Y; Sa-Ing V; Proprom N; Lertsithichai P; Jirasisrithum S; Kittur D
    Asian J Surg; 2010 Oct; 33(4):193-8. PubMed ID: 21377106
    [TBL] [Abstract][Full Text] [Related]  

  • 30. An initial evaluation of a proof-of-concept 128-Hz electronic tuning fork in the detection of peripheral neuropathy.
    O'Brien T; Karem J
    J Am Podiatr Med Assoc; 2014 Mar; 104(2):134-40. PubMed ID: 24725032
    [TBL] [Abstract][Full Text] [Related]  

  • 31. Difficulties in screening for peripheral neuropathies in children with diabetes.
    Hirschfeld G; von Glischinski M; Knop C; Wiesel T; Reinehr T; Aksu F; Blankenburg M; Hirsch J; Zernikow B
    Diabet Med; 2015 Jun; 32(6):786-9. PubMed ID: 25640325
    [TBL] [Abstract][Full Text] [Related]  

  • 32. The use of exploratory analyses within the National Institute for Health and Care Excellence single technology appraisal process: an evaluation and qualitative analysis.
    Kaltenthaler E; Carroll C; Hill-McManus D; Scope A; Holmes M; Rice S; Rose M; Tappenden P; Woolacott N
    Health Technol Assess; 2016 Apr; 20(26):1-48. PubMed ID: 27049841
    [TBL] [Abstract][Full Text] [Related]  

  • 33. [Examination of peripheral sensibility. Vibration test is more sensitive than monofilament test].
    Sörman E; Edwall LL
    Lakartidningen; 2002 Mar; 99(12):1339-40. PubMed ID: 11998167
    [TBL] [Abstract][Full Text] [Related]  

  • 34. Cost-effectiveness analysis of the Neuropad device as a screening tool for early diabetic peripheral neuropathy.
    Rodríguez-Sánchez B; Peña-Longobardo LM; Sinclair AJ
    Eur J Health Econ; 2020 Apr; 21(3):335-349. PubMed ID: 31720872
    [TBL] [Abstract][Full Text] [Related]  

  • 35. Back to basics: ankle reflex in the evaluation of peripheral neuropathy in type 2 diabetes mellitus.
    Shehab DK; Al-Jarallah KF; Abraham M; Mojiminiyi OA; Al-Mohamedy H; Abdella NA
    QJM; 2012 Apr; 105(4):315-20. PubMed ID: 22071964
    [TBL] [Abstract][Full Text] [Related]  

  • 36. Proposal of a new method for the use of the Rydel-Seiffer tuning fork in the screening of diabetic polyneuropathy. A pilot study.
    de Simone R; Rabitti PG; De Feo EM; Manguso F; Piscopo G; Scionti L
    Diabetes Res Clin Pract; 2015 May; 108(2):e21-4. PubMed ID: 25773377
    [TBL] [Abstract][Full Text] [Related]  

  • 37. A comparison of the new indicator test for sudomotor function (Neuropad) with the vibration perception threshold and the clinical examination in the diagnosis of peripheral neuropathy in subjects with type 2 diabetes.
    Papanas N; Papatheodorou K; Papazoglou D; Monastiriotis C; Christakidis D; Maltezos E
    Exp Clin Endocrinol Diabetes; 2008 Feb; 116(2):135-8. PubMed ID: 18095233
    [TBL] [Abstract][Full Text] [Related]  

  • 38. Quantitative measurement of cutaneous perception in diabetic neuropathy.
    Vinik AI; Suwanwalaikorn S; Stansberry KB; Holland MT; McNitt PM; Colen LE
    Muscle Nerve; 1995 Jun; 18(6):574-84. PubMed ID: 7753119
    [TBL] [Abstract][Full Text] [Related]  

  • 39. NICE's use of cost effectiveness as an exemplar of a deliberative process.
    Culyer AJ
    Health Econ Policy Law; 2006 Jul; 1(Pt 3):299-318. PubMed ID: 18634698
    [TBL] [Abstract][Full Text] [Related]  

  • 40.
    ; ; . PubMed ID:
    [No Abstract]   [Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 7.